Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.

Item
http://www.wikidata.org/entity/Q39946562
Time to improve statin prescription guidelines in low-risk patients?Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.Targeting LDL Cholesterol: Beyond Absolute Goals Toward Personalized Risk.Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines.Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CarA Contemporary Estimate of Total Mortality and Cardiovascular Disease Risk in Young Adults With Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study.Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014.Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular DiseaseStatins alone or polypill for primary prevention of cardiovascular diseases.Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of CarPersonalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk Individuals.Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments.Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives.The Genetic Regulation of Aortic Valve Development and Calcific Disease
P2860

Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.

Item
http://www.wikidata.org/entity/Q39946562
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Individualized Statin Benefit ...... ion of Cardiovascular Disease.
@en
Individualized Statin Benefit ...... ion of Cardiovascular Disease.
@nl
type
label
Individualized Statin Benefit ...... ion of Cardiovascular Disease.
@en
Individualized Statin Benefit ...... ion of Cardiovascular Disease.
@nl
prefLabel
Individualized Statin Benefit ...... ion of Cardiovascular Disease.
@en
Individualized Statin Benefit ...... ion of Cardiovascular Disease.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Individualized Statin Benefit ...... ion of Cardiovascular Disease.
@en
P2093
P304
P31
P356
10.1161/CIRCULATIONAHA.115.018383
P407
P433
P478
P577
P698
P921